pharma · Endometrial Cancer · XBIO
Xenetic Biosciences
Xenetic Biosciences is a pharma organization headquartered in Framingham, USA. It trades on NYSE under ticker XBIO. Primary therapeutic focus areas include Endometrial Cancer. NovaPharmaNews links 1 clinical program(s),
Framingham, USA HQ
7 Employees
Public company Type
XBIO · NYSE Ticker
Company details
- Status
- Public
- HQ
- Framingham, USA
- Employees
- 7
- Programs
- 1
- Drugs
- 1
- Patents
- 1
Sodium Cridanimod
Phase 2 · small molecule · Endometrial Cancer
Sodium Cridanimod for Endometrial Cancer is a Phase 2 program (small_molecule) at Xenetic Biosciences with 1 ClinicalTrials.gov record(s).
Internal code VX-EC-2-02
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Xenetic Biosciences
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Endometrial Cancer
- Status
- terminated
- Trials
- 1